Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.
Nemolizumab monotherapy may be an effective treatment for reducing pruritus and disease severity in adults with moderate to severe prurigo nodularis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback